메뉴 건너뛰기




Volumn 47, Issue 1, 2004, Pages 39-45

Associated response in bone and lipids during hormone replacement therapy

Author keywords

Bone mineral density; Cardiovascular disease; Cholesterol; Hormone replacement therapy; LDL; Postmenopausal osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; CHOLESTEROL; ESTRADIOL; GESTODENE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL;

EID: 0346998041     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00225-1     Document Type: Article
Times cited : (8)

References (33)
  • 1
    • 0024556687 scopus 로고
    • Reduced bone mass in daughters of women with osteoporosis
    • Seeman E., Hopper J.L., Bach L.A., et al. Reduced bone mass in daughters of women with osteoporosis. New Engl. J. Med. 320:1989;554-558.
    • (1989) New Engl. J. Med. , vol.320 , pp. 554-558
    • Seeman, E.1    Hopper, J.L.2    Bach, L.A.3
  • 2
    • 0025812532 scopus 로고
    • Genetic determinants of bone mass in adult women: A revaluation of the twin model and of the potential importance of gene interaction on heritability estimates
    • Slemenda C.W., Christian J.C., Williams C.J., Norton J.A., Johnston C.C. Jr. Genetic determinants of bone mass in adult women: a revaluation of the twin model and of the potential importance of gene interaction on heritability estimates. J. Bone Miner. Res. 6:1991;561-567.
    • (1991) J. Bone Miner. Res. , vol.6 , pp. 561-567
    • Slemenda, C.W.1    Christian, J.C.2    Williams, C.J.3    Norton, J.A.4    Johnston Jr., C.C.5
  • 4
    • 0019208916 scopus 로고
    • Decreased risk of fractures of the hip and lower forearm with postmenopausal use of oestrogen
    • Weiss N.S., Ure C.L., Ballard J.H., Williams A.R., Daling J.R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of oestrogen. New Engl. J. Med. 0303:1980;1195-1198.
    • (1980) New Engl. J. Med. , vol.303 , pp. 1195-1198
    • Weiss, N.S.1    Ure, C.L.2    Ballard, J.H.3    Williams, A.R.4    Daling, J.R.5
  • 5
    • 0023229530 scopus 로고
    • Hip fracture and the use of estrogens in postmenopausal women. The Framingham study
    • Kiel D.P., Felson D.T., Anderson J.J., Wilson P.W., Moskowitz M.A. Hip fracture and the use of estrogens in postmenopausal women. The Framingham study. New Engl. J. Med. 317:1987;1169-1174.
    • (1987) New Engl. J. Med. , vol.317 , pp. 1169-1174
    • Kiel, D.P.1    Felson, D.T.2    Anderson, J.J.3    Wilson, P.W.4    Moskowitz, M.A.5
  • 6
    • 0021037480 scopus 로고
    • The effect of oestrogen dose on postmenopausal bone loss
    • Horsman A., Jones M., Francis R., Nordin C. The effect of oestrogen dose on postmenopausal bone loss. New Engl. J. Med. 309:1983;1405-1407.
    • (1983) New Engl. J. Med. , vol.309 , pp. 1405-1407
    • Horsman, A.1    Jones, M.2    Francis, R.3    Nordin, C.4
  • 7
    • 0021271265 scopus 로고
    • The minimum effective dose of oestrogen for prevention of postmenopausal bone loss
    • Lindsay R., Hart D.M., Clark D.M. The minimum effective dose of oestrogen for prevention of postmenopausal bone loss. Obstet. Gynecol. 63:(6):1984;759-763.
    • (1984) Obstet. Gynecol. , vol.63 , Issue.6 , pp. 759-763
    • Lindsay, R.1    Hart, D.M.2    Clark, D.M.3
  • 9
    • 0024997302 scopus 로고
    • 17-β. Estradiol and continuous norethisterone: A unique treatment of established osteoporosis in elderly women
    • Christiansen C., Riis B.J. 17-β. Estradiol and continuous norethisterone: a unique treatment of established osteoporosis in elderly women. J. Clin. Enocrinol. Metab. 71:1990;836-841.
    • (1990) J. Clin. Enocrinol. Metab. , vol.71 , pp. 836-841
    • Christiansen, C.1    Riis, B.J.2
  • 10
    • 0033783084 scopus 로고    scopus 로고
    • Changes in LDL density across the menopausal transition
    • Carr M.C., Kim K.H., Zambon A., et al. Changes in LDL density across the menopausal transition. J. Invest. Med. 48:(4):2000;245-250.
    • (2000) J. Invest. Med. , vol.48 , Issue.4 , pp. 245-250
    • Carr, M.C.1    Kim, K.H.2    Zambon, A.3
  • 11
    • 0026234752 scopus 로고
    • Extraskeletal effects of oestrogen and the prevention of atherosclerosis
    • Bush T.L. Extraskeletal effects of oestrogen and the prevention of atherosclerosis. Osteporosis Int. 2:1991;5-11.
    • (1991) Osteporosis Int. , vol.2 , pp. 5-11
    • Bush, T.L.1
  • 12
    • 0032552636 scopus 로고    scopus 로고
    • Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease
    • Van der Mooren M.J., Mijatovic V., Van Baal W.M., Stehouwer C.D. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease. Maturitas. 30:1998;27-36.
    • (1998) Maturitas , vol.30 , pp. 27-36
    • Van Der Mooren, M.J.1    Mijatovic, V.2    Van Baal, W.M.3    Stehouwer, C.D.4
  • 13
    • 0025940856 scopus 로고
    • Postmenopausal oestrogen therapy in cardiovascular disease: Ten year follow-up from the nurses' health study
    • Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal oestrogen therapy in cardiovascular disease: ten year follow-up from the nurses' health study. New Engl. J. Med. 325:1991;756-762.
    • (1991) New Engl. J. Med. , vol.325 , pp. 756-762
    • Stampfer, M.J.1    Colditz, G.A.2    Willett, W.C.3
  • 14
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    • Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J. Am. Med. Assoc. 280:1998;605-613.
    • (1998) J. Am. Med. Assoc. , vol.280 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3
  • 15
    • 0034710627 scopus 로고    scopus 로고
    • Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
    • Herrington D.M., Reboussin D.M., Broshnihan K.B., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. New Engl. J. Med. 343:2000;522-529.
    • (2000) New Engl. J. Med. , vol.343 , pp. 522-529
    • Herrington, D.M.1    Reboussin, D.M.2    Broshnihan, K.B.3
  • 16
    • 0036898962 scopus 로고    scopus 로고
    • Perspectives on the women's health initiative trial of hormone replacement therapy
    • Grimes D.A., Lobo R.A. Perspectives on the women's health initiative trial of hormone replacement therapy. Obstet. Gynecol. 100:2002;1344-1353.
    • (2002) Obstet. Gynecol. , vol.100 , pp. 1344-1353
    • Grimes, D.A.1    Lobo, R.A.2
  • 17
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomised controlled trial
    • Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomised controlled trial. J. Am. Med. Assoc. 288:2002;321-333.
    • (2002) J. Am. Med. Assoc. , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 18
    • 0034122281 scopus 로고    scopus 로고
    • Three year study of oestrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia
    • Sanada M., Nakagawa H., Kodoma I., Sakasita T., Ohama K. Three year study of oestrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia. Metabolism. 49:(6):2000;784-789.
    • (2000) Metabolism , vol.49 , Issue.6 , pp. 784-789
    • Sanada, M.1    Nakagawa, H.2    Kodoma, I.3    Sakasita, T.4    Ohama, K.5
  • 20
    • 0025752582 scopus 로고
    • Serum lipids, lipoproteins and apolipoproteins during postmenopausal oestrogen replacement therapy combined with either 19-nortestosterone derivates or 17-hydroxyprogesterone derivates
    • Haarbo J., Hassager C., Jensen S.B., Riis B.J., Christiansen C. Serum lipids, lipoproteins and apolipoproteins during postmenopausal oestrogen replacement therapy combined with either 19-nortestosterone derivates or 17-hydroxyprogesterone derivates. Am. J. Med. 90:1991;584-589.
    • (1991) Am. J. Med. , vol.90 , pp. 584-589
    • Haarbo, J.1    Hassager, C.2    Jensen, S.B.3    Riis, B.J.4    Christiansen, C.5
  • 21
    • 0034065195 scopus 로고    scopus 로고
    • Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women
    • Bjarnason N.H., Christiansen C. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone. 26:(6):2000;561-569.
    • (2000) Bone , vol.26 , Issue.6 , pp. 561-569
    • Bjarnason, N.H.1    Christiansen, C.2
  • 22
    • 0030890138 scopus 로고    scopus 로고
    • Sex steroids and the cardiovascular system
    • Christiansen C. Sex steroids and the cardiovascular system. Osteoporosis Int. 7:(Suppl. 1):1997;S8-11.
    • (1997) Osteoporosis Int. , vol.7 , Issue.SUPPL. 1 , pp. 8-11
    • Christiansen, C.1
  • 23
    • 0030846737 scopus 로고    scopus 로고
    • Association of bone mineral density with apolipoprotein e phenotype
    • Shiraki M., Shiraki Y., Aoki C., et al. Association of bone mineral density with apolipoprotein E phenotype. J. Bone Miner. Res. 12:(9):1997;1438-1445.
    • (1997) J. Bone Miner. Res. , vol.12 , Issue.9 , pp. 1438-1445
    • Shiraki, M.1    Shiraki, Y.2    Aoki, C.3
  • 24
    • 0035131143 scopus 로고    scopus 로고
    • Estrogens, lipids and cardiovascular disease: No easy answers
    • Bittner V. Estrogens, lipids and cardiovascular disease: no easy answers. JACC. 37:(2):2001;431-433.
    • (2001) JACC , vol.37 , Issue.2 , pp. 431-433
    • Bittner, V.1
  • 25
    • 0034650274 scopus 로고    scopus 로고
    • Does apolipoprotein e genotype relate to BMD and bone markers in postmenopausal women
    • Heikkinen A.M., Kroger H., Niskanen L., et al. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women. Maturitas. 34:(1):2000;33-41.
    • (2000) Maturitas , vol.34 , Issue.1 , pp. 33-41
    • Heikkinen, A.M.1    Kroger, H.2    Niskanen, L.3
  • 27
    • 0033521078 scopus 로고    scopus 로고
    • Stimulation of bone formation in vitro and in rodents by statins
    • Mundy G., Garret R., Harris S., et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 286:1999;1946-1949.
    • (1999) Science , vol.286 , pp. 1946-1949
    • Mundy, G.1    Garret, R.2    Harris, S.3
  • 28
    • 0034709764 scopus 로고    scopus 로고
    • Oral statin and increase in bone mineral density in postmenopausal women
    • Edwards C.J., Hart D.J., Spector T.D. Oral statin and increase in bone mineral density in postmenopausal women. Lancet. 355:2000;2218-2219.
    • (2000) Lancet , vol.355 , pp. 2218-2219
    • Edwards, C.J.1    Hart, D.J.2    Spector, T.D.3
  • 29
    • 0031977199 scopus 로고    scopus 로고
    • Nitrogen-containing biphosphonates inhibit the mevalonate pathway and prevent post-translocational prenylation of GTP-binding proteins, including RAS
    • Luckman S.P., Hughes D.E., Coxon F.P., Graham R., Russel G., Rogers M.J. Nitrogen-containing biphosphonates inhibit the mevalonate pathway and prevent post-translocational prenylation of GTP-binding proteins, including RAS. J. Bone Miner. Res. 13:1998;581-589.
    • (1998) J. Bone Miner. Res. , vol.13 , pp. 581-589
    • Luckman, S.P.1    Hughes, D.E.2    Coxon, F.P.3    Graham, R.4    Russel, G.5    Rogers, M.J.6
  • 31
    • 0000128416 scopus 로고    scopus 로고
    • Does statin reduce risk of fracture in postmenopausal women? Results from the women's health initiative observational study (WHI-OS)
    • La Croix A.Z., Cauley J.S., Jackson R., et al. Does statin reduce risk of fracture in postmenopausal women? Results from the women's health initiative observational study (WHI-OS). J. Bone Miner. Res. 15:(Suppl. 1):2000;S155.
    • (2000) J. Bone Miner. Res. , vol.15 , Issue.SUPPL. 1 , pp. 155
    • La Croix, A.Z.1    Cauley, J.S.2    Jackson, R.3
  • 32
    • 0035901052 scopus 로고    scopus 로고
    • Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomised controlled trial
    • Reid I.R., Hague W., Emberson J., et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Lancet. 357:2001;509-512.
    • (2001) Lancet , vol.357 , pp. 509-512
    • Reid, I.R.1    Hague, W.2    Emberson, J.3
  • 33
    • 0037170846 scopus 로고    scopus 로고
    • Estrogen receptor alpha ploymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen
    • Kobayashi N., Fujino T., Shirogane T., et al. Estrogen receptor alpha ploymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas. 41:2002;193-201.
    • (2002) Maturitas , vol.41 , pp. 193-201
    • Kobayashi, N.1    Fujino, T.2    Shirogane, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.